Related Experiment Video
Updated: May 22, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating
1Division of Cancer Prevention, Department of Medicine, Stony Brook University, Stony Brook, NY 11794-8175, USA.
Abstract:
NO-aspirin (NO-ASA), consisting of aspirin and a nitric oxide-releasing group, is safer than aspirin and effective in colon cancer prevention. Here, we examined the mechanism of action of NO-ASA by focusing primarily on its effects on the cell cycle. NO-ASA reduced the growth of several cell lines from colon, pancreas, skin, cervix and breast cancer much more potently than aspirin, with 24-h IC(50) values of 133-268 µM, while those of ASA were >1,000 µM. NO-ASA elevated the intracellular levels of reactive oxygen species, generating a state of oxidative stress. In all cell lines examined, NO-ASA induced cell cycle arrest in the G(2)/M phase transition accompanied by altered expression of G(2)/M transition-related proteins. In SW480 colon cancer cells NO-ASA modulated proteins controlling this transition. Thus, it markedly increased the levels of cyclin B1, decreased the expression of cyclin D1 and Cdc25C, and increased the Thr14/Tyr15-phosphorylation of Cdk1 while leaving unchanged its protein levels. These changes, including the G2/M arrest, were prevented by pretreating the cells with the anti-oxidant N-acetyl-cysteine, indicating that redox signaling is likely responsible for the cell cycle changes, a conclusion consistent with the known redox regulation of these proteins. Collectively, these results confirm the profound cytokinetic effect of NO-ASA and provide strong evidence that it regulates cell cycle transitions through its ability to induce oxidative stress, which activates redox signaling in the target cell.
Insights
NO-aspirin (NO-ASA) is a safer, more potent colon cancer preventative than aspirin. It halts cancer cell growth by inducing oxidative stress and G2/M cell cycle arrest through redox signaling.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aspirin (ASA) is effective in cancer prevention, but has gastrointestinal side effects.
- Nitric oxide-releasing aspirin (NO-ASA) offers a potentially safer alternative.
- Understanding NO-ASA's mechanism of action is crucial for its therapeutic application.
Purpose of the Study:
- To investigate the mechanism by which NO-ASA inhibits cancer cell growth, focusing on its effects on the cell cycle.
- To compare the potency of NO-ASA and aspirin in inhibiting the growth of various cancer cell lines.
Main Methods:
- NO-ASA and aspirin efficacy were assessed by measuring 24-h IC(50) values across multiple cancer cell lines (colon, pancreas, skin, cervix, breast).
- Intracellular reactive oxygen species (ROS) levels were measured to assess oxidative stress induction.
- Cell cycle progression and the expression of key cell cycle regulatory proteins (cyclin B1, cyclin D1, Cdc25C, Cdk1) were analyzed in NO-ASA-treated cells.
- The role of oxidative stress was confirmed using the antioxidant N-acetyl-cysteine (NAC).
Main Results:
- NO-ASA demonstrated significantly greater potency than aspirin in inhibiting cancer cell growth (IC(50) 133-268 µM vs. >1,000 µM).
- NO-ASA elevated intracellular ROS levels, inducing oxidative stress.
- NO-ASA caused cell cycle arrest at the G(2)/M phase transition in all tested cell lines.
- Specific modulation of G(2)/M proteins was observed in SW480 colon cancer cells, including increased cyclin B1, decreased cyclin D1 and Cdc25C, and increased Cdk1 phosphorylation.
- The observed effects, including G(2)/M arrest, were reversed by NAC treatment, confirming the involvement of oxidative stress and redox signaling.
Conclusions:
- NO-ASA exhibits a potent cytokinetic effect, significantly inhibiting cancer cell growth more effectively than aspirin.
- NO-ASA's mechanism involves the induction of oxidative stress, which subsequently activates redox signaling pathways.
- These redox signaling events lead to cell cycle arrest at the G(2)/M phase by modulating key regulatory proteins, providing a clear mechanism for its anti-cancer activity.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Nitric Oxide Signaling Pathway
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage Can Stall the Cell Cycle

